Cancer Screening Guidelines: A Practical Summary for Patients

Screening recommendations change frequently and vary by organization. This guide cuts through the noise and explains what screenings are recommended, at what age, and why.

Cancer screening guidelines are among the most frequently updated — and most frequently misunderstood — recommendations in preventive medicine. Patients often arrive at appointments having read conflicting information online, unsure whether they are overdue for a test or whether a test they received was even necessary. This guide is intended to provide clarity.

Colorectal Cancer

The U.S. Preventive Services Task Force (USPSTF) recommends screening for colorectal cancer beginning at age 45 for average-risk adults, continuing through age 75. Several screening options exist: colonoscopy every 10 years remains the most comprehensive, as it allows for both detection and removal of polyps in a single procedure. Annual stool-based tests (FIT or high-sensitivity guaiac FOBT) are appropriate alternatives for patients who decline colonoscopy. Stool DNA testing (Cologuard) is an option every one to three years.

Patients with a first-degree relative diagnosed with colorectal cancer before age 60 should begin screening at age 40, or ten years before the relative's diagnosis — whichever comes first.

Breast Cancer

Mammography recommendations vary by organization, which is a genuine source of patient confusion. The USPSTF recommends biennial mammography for women aged 40 to 74. The American Cancer Society recommends annual mammography beginning at 45, with the option to begin at 40. I discuss individual risk factors with each patient and arrive at a shared decision about timing and frequency.

Women with a family history of breast or ovarian cancer, or known BRCA1/2 mutations, require earlier and more intensive screening — typically beginning at 30 with annual MRI in addition to mammography.

Cervical Cancer

Cervical cancer screening has become highly effective with the integration of HPV co-testing. Current recommendations: Pap smear alone every 3 years for women aged 21 to 29; Pap smear plus HPV co-test every 5 years (or Pap alone every 3 years) for women aged 30 to 65. Women who have had a total hysterectomy for benign disease do not require continued cervical screening.

Lung Cancer

Annual low-dose CT (LDCT) of the chest is recommended for adults aged 50 to 80 who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. This recommendation is frequently overlooked. If you or a family member meets these criteria, please discuss LDCT screening at your next visit.

Prostate Cancer

PSA-based prostate cancer screening is a shared decision-making conversation, not a blanket recommendation. The USPSTF recommends that men aged 55 to 69 discuss the potential benefits and harms of PSA screening with their physician before deciding. I have this conversation with every eligible male patient, taking into account family history, race (Black men have higher incidence and mortality), and individual preferences regarding the possibility of overdiagnosis and overtreatment.

A Note on Screening Intervals

Screening intervals are population-level recommendations. Individual risk factors — family history, genetic mutations, prior abnormal results, comorbidities — may warrant more frequent or earlier screening. The most important step is to have an ongoing conversation with your physician about which screenings apply to you and when.